Wick Capital Partners, LLC

Position in EXEL — Exelixis, Inc.

CIK 1904388 WAYNE, PA

Position in EXEL

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$203,547

-$30,987 QoQ

Shares Held

3,741

-30.1% QoQ

Ownership

0.002%

of shares outstanding

% of Portfolio

0.15%

of 13F equity value

Holder Rank

#585

of 751 holders

Holding Since

Dec 2025

2 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Wick Capital Partners, LLC holds $600,789 across 3 Biotechnology names. EXEL ranks #2 (33.9% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	BMRN	Biomarin Pharmaceutical Inc	3,687	$210,970
2	EXEL	Exelixis, Inc. This page	3,741	$203,547
3	VKTX	Viking Therapeutics, Inc.	4,775	$186,272

2 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$203,547	3,741	-30.1%	Shares	Sole	2026-08-14
2025-12-31	$234,534	5,351	—	Shares	Sole	2026-03-02
No filing history on record for this holder in this stock.